Dignitana to exhibit at Onkologidagarna in Malmö
Dignitana AB, scalp cooling innovation leader, will present the advanced technology of the DigniCap Delta Scalp Cooling System at Onkologidagarna held March 19 - 21 in Malmö Sweden.
With a theme of "Oncology of the future - in Sweden and in the world,” the event brings together oncology nurses and palliative medicine clinicians from across Sweden to exchange information and experience between clinical professionals and industry leaders.
“As we continue to grow the business and expand our global presence, we appreciate this opportunity to showcase the state-of the-art technology in DigniCap Delta to the oncology community in our home market of Sweden. Scalp cooling is an important quality of life improvement for cancer patients, and the investments we are making now support our ongoing commitment to superior clinical outcomes and progress to increase patient access to this treatment ,“ said Catarina Löwenadler, CEO of Dignitana.
Scalp cooling to minimize hair loss from chemotherapy is listed as a treatment recommendation in the clinical practice guidelines published by European Society for Medical Oncology (ESMO), National Comprehensive Cancer Network® (NCCN) and Cancer Australia.
For More Information Contact
Melissa Bourestom, Chief Communications Officer, melissa.bourestom@dignitana.com +1 469-518-5031
About Dignitana
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com.
Tags:
